Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 135,950 | -23,398 | -80,008 | -62,000 | -41,188 |
| Depreciation Amortization | 2,962 | 1,338 | 4,199 | 3,172 | 2,044 |
| Accounts payable and accrued liabilities | 2,713 | 943 | -4,564 | -6,310 | -1,756 |
| Other Working Capital | -126,037 | -282 | 10,612 | 11,060 | 14,969 |
| Other Operating Activity | 4,652 | 7,072 | 17,857 | 18,060 | 7,018 |
| Operating Cash Flow | $20,240 | $-14,327 | $-51,904 | $-36,018 | $-18,913 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 14,827 | 14,827 | 7,527 |
| PPE Investments | -428 | -74 | -2,198 | -2,095 | -1,951 |
| Purchase Sale Intangibles | -396 | -268 | -1,308 | -1,144 | -988 |
| Other Investing Activity | -396 | -268 | -1,358 | -1,144 | -988 |
| Investing Cash Flow | $-824 | $-342 | $11,271 | $11,588 | $4,588 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -933 | -379 | -1,487 | -1,109 | -736 |
| Common Stock Issued | 2,910 | 128 | 58,938 | 58,769 | 23,053 |
| Financing Cash Flow | $1,977 | $-251 | $57,451 | $57,660 | $22,317 |
| Beginning Cash Position | 40,362 | 40,362 | 23,544 | 24,243 | 24,243 |
| End Cash Position | 61,755 | 25,442 | 40,362 | 57,473 | 32,235 |
| Net Cash Flow | $21,393 | $-14,920 | $16,818 | $33,230 | $7,992 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,240 | -14,327 | -51,904 | -36,018 | -18,913 |
| Capital Expenditure | -428 | -74 | -2,198 | -2,095 | -1,951 |
| Free Cash Flow | 19,812 | -14,401 | -54,102 | -38,113 | -20,864 |